Print Page

藥 物 回 收

 
The United States: Indiana Botanic Gardens, Inc. Issues Allergy Alert on Undeclared Peanuts in Prune & Senna Softgels (English only)
 
The US Food and Drug Administration (FDA) announces that Indiana Botanic Gardens Inc. of Indiana, is recalling its 30-count bottles of Botanic Choice brand Prune & Senna Softgels (contains sennosides) because they may contain undeclared peanuts. People who have allergies to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.
The recalled Prune & Senna Softgels were distributed nationwide in retail store and through online and mail orders.
The product comes in a 30-count, white plastic bottle marked with lot # 6105193 on the bottom and with a manufacturing date of 03-2022 stamped on the label.
No illnesses have been reported to date in connection with this issue.
The recall was initiated after it was discovered that the peanut-containing product was distributed in packaging that did not reveal the presence of peanuts. Subsequent investigation indicates the problem was caused by an accidental contamination of the one of the raw materials in the product.

Please refer to the following website in FDA for details: http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/indiana-botanic-gardens-inc-issues-allergy-alert-undeclared-peanuts-prune-senna-softgels

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Saturday, May 28, 2022
Issued at HKT 12:00

 
 
back